503 related articles for article (PubMed ID: 32078212)
1. Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome.
Nitsche C; Aschauer S; Kammerlander AA; Schneider M; Poschner T; Duca F; Binder C; Koschutnik M; Stiftinger J; Goliasch G; Siller-Matula J; Winter MP; Anvari-Pirsch A; Andreas M; Geppert A; Beitzke D; Loewe C; Hacker M; Agis H; Kain R; Lang I; Bonderman D; Hengstenberg C; Mascherbauer J
Eur J Heart Fail; 2020 Oct; 22(10):1852-1862. PubMed ID: 32078212
[TBL] [Abstract][Full Text] [Related]
2. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
Castaño A; Narotsky DL; Hamid N; Khalique OK; Morgenstern R; DeLuca A; Rubin J; Chiuzan C; Nazif T; Vahl T; George I; Kodali S; Leon MB; Hahn R; Bokhari S; Maurer MS
Eur Heart J; 2017 Oct; 38(38):2879-2887. PubMed ID: 29019612
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis.
Nitsche C; Scully PR; Patel KP; Kammerlander AA; Koschutnik M; Dona C; Wollenweber T; Ahmed N; Thornton GD; Kelion AD; Sabharwal N; Newton JD; Ozkor M; Kennon S; Mullen M; Lloyd G; Fontana M; Hawkins PN; Pugliese F; Menezes LJ; Moon JC; Mascherbauer J; Treibel TA
J Am Coll Cardiol; 2021 Jan; 77(2):128-139. PubMed ID: 33181246
[TBL] [Abstract][Full Text] [Related]
4. Transthyretin cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: experience of a single center.
Gallone G; Bongiovanni C; Bruno F; Landra F; Andreis A; Fava A; Scudeler L; DE Filippo O; Califaretti E; Cioffi M; Pidello S; Vairo A; Raineri C; Frea S; Giorgi M; Alunni G; Casoni R; Salizzoni S; Conrotto F; D'Ascenzo F; Rinaldi M; DE Ferrari GM
Minerva Cardiol Angiol; 2024 Feb; 72(1):87-94. PubMed ID: 37405712
[TBL] [Abstract][Full Text] [Related]
5. Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis.
Rosenblum H; Masri A; Narotsky DL; Goldsmith J; Hamid N; Hahn RT; Kodali S; Vahl T; Nazif T; Khalique OK; Bokhari S; Soman P; Cavalcante JL; Maurer MS; Castaño A
Eur J Heart Fail; 2021 Feb; 23(2):250-258. PubMed ID: 32729170
[TBL] [Abstract][Full Text] [Related]
6. Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis.
Cavalcante JL; Rijal S; Abdelkarim I; Althouse AD; Sharbaugh MS; Fridman Y; Soman P; Forman DE; Schindler JT; Gleason TG; Lee JS; Schelbert EB
J Cardiovasc Magn Reson; 2017 Dec; 19(1):98. PubMed ID: 29212513
[TBL] [Abstract][Full Text] [Related]
7. Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement.
Treibel TA; Fontana M; Gilbertson JA; Castelletti S; White SK; Scully PR; Roberts N; Hutt DF; Rowczenio DM; Whelan CJ; Ashworth MA; Gillmore JD; Hawkins PN; Moon JC
Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27511979
[TBL] [Abstract][Full Text] [Related]
8. Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot Study.
Singal AK; Bansal R; Singh A; Dorbala S; Sharma G; Gupta K; Saxena A; Bhargava B; Karthikeyan G; Ramakrishnan S; Bisoi AK; Hote MP; Rajashekar P; Chowdhury UK; Devagourou V; Patel C; Ray R; Arawa SK; Mishra S
JACC CardioOncol; 2021 Oct; 3(4):565-576. PubMed ID: 34746852
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Amyloidosis in Patients Undergoing TAVR: Why We Need to Think About It.
Cappelli F; Perfetto F; Martone R; Di Mario C
Cardiovasc Revasc Med; 2021 Jan; 22():109-114. PubMed ID: 32571759
[TBL] [Abstract][Full Text] [Related]
10. Transthyretin cardiac amyloidosis in patients after TAVR: clinical and echocardiographic findings and long term survival.
Shimoni S; Zikri M; Haberman D; Livschitz S; Tshori S; Fabricant Y; Meledin V; Gandelman G; Goland S; George J
ESC Heart Fail; 2021 Dec; 8(6):4549-4561. PubMed ID: 34704399
[TBL] [Abstract][Full Text] [Related]
11. Histological assessment of cardiac amyloidosis in patients undergoing transcatheter aortic valve replacement.
Beuthner BE; Elkenani M; Evert K; Mustroph J; Jacob CF; Paul NB; Beißbarth T; Zeisberg EM; Schnelle M; Puls M; Hasenfuß G; Toischer K
ESC Heart Fail; 2024 Jun; 11(3):1636-1646. PubMed ID: 38407567
[TBL] [Abstract][Full Text] [Related]
12. Concomitant transthyretin cardiac amyloidosis in patients undergoing TAVR for aortic stenosis: A systemic review and meta-analysis.
Fatima K; Uddin QS; Tharwani ZH; Kashif MAB; Javaid SS; Kumar P; Zia MT; Javed M; Butt MS; Asim Z
Int J Cardiol; 2024 May; 402():131854. PubMed ID: 38367883
[TBL] [Abstract][Full Text] [Related]
13. Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis.
Ternacle J; Bodez D; Guellich A; Audureau E; Rappeneau S; Lim P; Radu C; Guendouz S; Couetil JP; Benhaiem N; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Mohty D; Deux JF; Damy T
JACC Cardiovasc Imaging; 2016 Feb; 9(2):126-38. PubMed ID: 26777222
[TBL] [Abstract][Full Text] [Related]
14. Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications.
Balciunaite G; Rimkus A; Zurauskas E; Zaremba T; Palionis D; Valeviciene N; Aidietis A; Serpytis P; Rucinskas K; Sogaard P; Glaveckaite S; Zorinas A; Janusauskas V
Hellenic J Cardiol; 2020; 61(2):92-98. PubMed ID: 31740363
[TBL] [Abstract][Full Text] [Related]
15. Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis.
Oike F; Usuku H; Yamamoto E; Marume K; Takashio S; Ishii M; Tabata N; Fujisue K; Yamanaga K; Sueta D; Hanatani S; Arima Y; Araki S; Oda S; Kawano H; Soejima H; Matsushita K; Ueda M; Fukui T; Tsujita K
ESC Heart Fail; 2022 Jun; 9(3):1976-1986. PubMed ID: 35338611
[TBL] [Abstract][Full Text] [Related]
16. Reverse Remodeling Following Valve Replacement in Coexisting Aortic Stenosis and Transthyretin Cardiac Amyloidosis.
Nitsche C; Koschutnik M; Donà C; Radun R; Mascherbauer K; Kammerlander A; Heitzinger G; Dannenberg V; Spinka G; Halavina K; Winter MP; Calabretta R; Hacker M; Agis H; Rosenhek R; Bartko P; Hengstenberg C; Treibel T; Mascherbauer J; Goliasch G
Circ Cardiovasc Imaging; 2022 Jul; 15(7):e014115. PubMed ID: 35861981
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and outcomes of concomitant cardiac amyloidosis and aortic stenosis: A systematic review and meta-analysis.
Ho JS; Kor Q; Kong WK; Lim YC; Chan MY; Syn NL; Ngiam JN; Chew NW; Yeo TC; Chai P; Poh KK; Wong RC; Lin W; Sia CH
Hellenic J Cardiol; 2022; 64():67-76. PubMed ID: 34856378
[TBL] [Abstract][Full Text] [Related]
18. Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients.
Scully PR; Patel KP; Saberwal B; Klotz E; Augusto JB; Thornton GD; Hughes RK; Manisty C; Lloyd G; Newton JD; Sabharwal N; Kelion A; Kennon S; Ozkor M; Mullen M; Hartman N; Cavalcante JL; Menezes LJ; Hawkins PN; Treibel TA; Moon JC; Pugliese F
JACC Cardiovasc Imaging; 2020 Oct; 13(10):2177-2189. PubMed ID: 32771574
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of right ventricular systolic function in cardiac amyloidosis.
Bodez D; Ternacle J; Guellich A; Galat A; Lim P; Radu C; Guendouz S; Bergoend E; Couetil JP; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Deux JF; Mohty D; Damy T
Amyloid; 2016 Sep; 23(3):158-167. PubMed ID: 27348696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
